- Home
- ELTX vs FCEL Comparison
ELTX vs FCEL Comparison
Compare ELTX & FCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- FCEL
- Stock Information
- Founded
- ELTX 2011
- FCEL 1969
- Country
- ELTX United States
- FCEL United States
- Employees
- ELTX N/A
- FCEL N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- FCEL Industrial Machinery/Components
- Sector
- ELTX Health Care
- FCEL Energy
- Exchange
- ELTX Nasdaq
- FCEL Nasdaq
- Market Cap
- ELTX 121.7M
- FCEL 116.0M
- IPO Year
- ELTX N/A
- FCEL 1992
- Fundamental
- Price
- ELTX $8.09
- FCEL $5.39
- Analyst Decision
- ELTX Strong Buy
- FCEL Hold
- Analyst Count
- ELTX 2
- FCEL 6
- Target Price
- ELTX $9.50
- FCEL $14.11
- AVG Volume (30 Days)
- ELTX 46.9K
- FCEL 2.1M
- Earning Date
- ELTX 08-12-2025
- FCEL 09-04-2025
- Dividend Yield
- ELTX N/A
- FCEL N/A
- EPS Growth
- ELTX N/A
- FCEL N/A
- EPS
- ELTX N/A
- FCEL N/A
- Revenue
- ELTX N/A
- FCEL $129,424,000.00
- Revenue This Year
- ELTX N/A
- FCEL $40.32
- Revenue Next Year
- ELTX N/A
- FCEL $36.17
- P/E Ratio
- ELTX N/A
- FCEL N/A
- Revenue Growth
- ELTX N/A
- FCEL 48.62
- 52 Week Low
- ELTX $3.70
- FCEL $3.58
- 52 Week High
- ELTX $9.99
- FCEL $21.60
- Technical
- Relative Strength Index (RSI)
- ELTX 62.14
- FCEL 47.57
- Support Level
- ELTX $7.76
- FCEL $5.11
- Resistance Level
- ELTX $8.94
- FCEL $6.32
- Average True Range (ATR)
- ELTX 0.37
- FCEL 0.39
- MACD
- ELTX -0.03
- FCEL -0.07
- Stochastic Oscillator
- ELTX 51.09
- FCEL 23.31
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company operates in USA, South Korea, Europe and Canada. Majority of revenue is from USA and South Korea.